| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/27/2008 | WO2007138444A3 Genetic markers for high oleic acid content in plants |
| 03/27/2008 | WO2007134876A3 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY |
| 03/27/2008 | WO2007133290A8 Anti-ox40l antibodies and methods using same |
| 03/27/2008 | WO2007127219A3 Targeted delivery to leukocytes using protein carriers |
| 03/27/2008 | WO2007106800A3 In vivo induced genes of mycobacterium tuberculosis |
| 03/27/2008 | WO2007092939A3 Antigenic gm-csf peptides and antibodies to gm-csf |
| 03/27/2008 | WO2007064647A3 Peptide inhibitors of abl kinases |
| 03/27/2008 | WO2005117971A3 Regulators of angiogenesis |
| 03/27/2008 | WO2003075845A3 Immunogenicity of glucan binding protein |
| 03/27/2008 | US20080076906 Antagonists of neuropilin receptor function and use thereof |
| 03/27/2008 | US20080076905 Using broth comprising protein synthesis machinery and amino acids to produce an isotope-labeled protein for nuclear magnetic resonance three dimensional structural analysis of polypeptides |
| 03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/27/2008 | US20080076732 Gene expression control DNA element and associated protein |
| 03/27/2008 | US20080076727 antibody cocktails each recognizing a distinct epitope on the HMW-MAA protein; |
| 03/27/2008 | US20080076713 Peptides selectively lethal to malignant and transformed mammalian cells |
| 03/27/2008 | US20080076709 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 03/27/2008 | US20080076708 Active Variants of the Il-18 Binding Protein and Medical Uses Thereof |
| 03/27/2008 | US20080076175 Generating transgenic lymphoid cell comprising sequences coding immunoglobulin epitope for use in tissue targeted therapies |
| 03/27/2008 | US20080076143 Microfluidic system for proteome analysis |
| 03/27/2008 | US20080076141 Nucleotide sequences coding transferase for use in identifying modulators for prevention and treatment of cell proliferative diseases |
| 03/27/2008 | US20080076136 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement |
| 03/27/2008 | US20080075741 Recombinant P. falciparum merozoite protein-1 42 vaccine |
| 03/27/2008 | US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers |
| 03/27/2008 | US20080075736 Materials and methods for respiratory disease control in canines |
| 03/27/2008 | US20080075733 receptor for advanced glycosylation end products polypeptide directly linked to a polypeptide comprising a CH2 domain of an immunoglobulin; biodrug for treating amyloidosis, Alzheimer's disease, cancer, autoimmune disease, inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075726 Anti-IL-6 monoclonal antibodies and uses thereof |
| 03/27/2008 | US20080075725 Novel Immunointeractive Molecules and uses Thereof |
| 03/27/2008 | US20080075724 Nucleotide sequeces coding protein for use in the detection, diagnosis and treatment cell proliferative, autoimmune diseases, inflammation and infection; biodrugs as antiinflammatory agents, antiproliferative agents |
| 03/27/2008 | US20080075723 Endotheliase 2 ligands |
| 03/27/2008 | US20080075721 Method of treating fibrosis |
| 03/27/2008 | US20080075720 fusion proteins comprising antibody variable domains that binds to factor B and a targeting moiety comprising a complement receptor or fragment, used to reduce or prevent airway hyperresponsiveness and inflammation, for treating ischemia-reperfusion injuries, rhinitis and respiratory system disorders |
| 03/27/2008 | US20080075719 Method for Augmenting B Cell Depletion |
| 03/27/2008 | US20080075717 Antigen Imitating Extracellular Areas of Membrane Proteins of Type III Produced from Intracellular Pathogenic Micro-Organisms, Derived Conformational Antibodies and the Use Thereof |
| 03/27/2008 | US20080075716 purified and/or genetic engineered antibodies or fragments comprises variable heavy or light chain peptides capable of binding oxidized fragments of alipoproteins, used as vaccines against cardiovascular disorders |
| 03/27/2008 | US20080075715 modified polypeptides, whereby the modification results in a reduced number of potential lymphocyte epitopes that provides a reduced propensity for the polypeptide to elicit an immune response upon administration to a human, but retain the ability to bind to CD52 antigens |
| 03/27/2008 | US20080075712 replacement for ligand of a heteromolecule-comprising a dimer, cytokine or interferon receptors; antibodies recognizing both an enzyme and a substrate, such as proteolytic enzymes and blood coagulation/fibrinolysis associated factors; prevention of bleeding and/or blood disorders |
| 03/27/2008 | US20080075659 Determining the percentage of monoclonal, chimerized, murine or humanized antibody greater than 90 percent using excess amount of CD66 antigen, and the percentage of immunoreactive antibody that binds specifically to CD66 |
| 03/27/2008 | DE102007024383A1 Ddeodorant or antiperspirant composition comprises an antibody that is directed against a defined microorganism and is isolated from egg yolk |
| 03/27/2008 | DE102007024381A1 Topical composition for treating acne, pimples, bad skin or seborrhea comprises an antibody that is directed against a defined microorganism and is isolated from egg yolk |
| 03/27/2008 | DE102006042012A1 Verfahren zur Unterstützung von Immuntherapien Practices in support of immunotherapies |
| 03/27/2008 | CA2663994A1 Anti-cancer antibodies against lewisb and lewis antigens |
| 03/27/2008 | CA2663828A1 Binding molecules |
| 03/27/2008 | CA2663819A1 Phytases, nucleic acids encoding them and methods for making and using them |
| 03/27/2008 | CA2663001A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 03/27/2008 | CA2662613A1 Compositions and methods relating to glucagon receptor antibodies |
| 03/27/2008 | CA2660795A1 Optimized antibodies that target hm1.24 |
| 03/27/2008 | CA2649387A1 Novel gene disruptions, compositions and methods relating thereto |
| 03/27/2008 | CA2644273A1 Process for the production of a fine chemical |
| 03/26/2008 | EP1903115A1 Process for the fermentative production of antibodies |
| 03/26/2008 | EP1903112A2 Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family |
| 03/26/2008 | EP1903111A2 Extended cDNAs for secreted proteins |
| 03/26/2008 | EP1903058A2 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1901761A2 Thrombospondin-1 derived peptides and treatment methods |
| 03/26/2008 | EP1620072B1 Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 03/26/2008 | EP1179068B1 Interleukin-1 hy2 materials and methods |
| 03/26/2008 | EP1033953B1 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 03/26/2008 | EP0871482B1 Recombinant vesiculoviruses and their uses |
| 03/26/2008 | EP0714405B1 Therapeutic and diagnostic agents for amyloidosis |
| 03/26/2008 | EP0672147B1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 03/26/2008 | CN101151372A Protein and its use in diagnosing alzheimer's disease |
| 03/26/2008 | CN101151363A Plant virus designated tomato torrado virus |
| 03/26/2008 | CN101151279A Atazanavir conjugates and antibodies useful in immunoassay |
| 03/26/2008 | CN101151278A CD20 antibody variants and uses thereof |
| 03/26/2008 | CN101151277A Anti-interferon gamma antibodies and methods of use thereof |
| 03/26/2008 | CN101151276A Method of producing protein by using hamster IGF-1 |
| 03/26/2008 | CN101148670A Preparation for breast cancer monoclonal antibody M4G3 single-chain antibody and DNA sequence thereof |
| 03/26/2008 | CN101148474A Human resource vessel endothelium growth factor monoclonal antibody and preparation method thereof |
| 03/26/2008 | CN100376671C Hybridized tumour cell strain of anti hpatitis B virus surface antigen and its monoclonal antibody |
| 03/26/2008 | CN100376599C Recombining single chained three specific antibodies of anti CCA, anti CD 3, anti CD 28 through genetic engineering |
| 03/25/2008 | US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/25/2008 | US7348415 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 03/25/2008 | US7348414 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 03/25/2008 | US7348413 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferfative disorders; immunotherapy; immunodiagnostics |
| 03/25/2008 | US7348412 Ouabain-specific monoclonal antibodies |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348404 Solid-phase peptide synthesis and agent for use in such synthesis |
| 03/25/2008 | US7348403 Contacting a peptide with the agent under conditions permitting formation of a phosphorus-based ester; and determining whether a phosphorus-based ester has formed between the peptide and the agent; inactivation of organophosphorus-based insecticides and chemical warfare agents |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7348004 Immunoglobulin chimeric monomer-dimer hybrids |
| 03/25/2008 | US7348003 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders |
| 03/25/2008 | US7348002 peptides and monoclonal antibodies used as blocking agents, that disrupt the interaction between collagen and integrins; prophylaxis of inflammatory diseases |
| 03/25/2008 | US7348001 Protein that includes a heavy chain immunoglobulin variable domain sequence and a light chain immunoglobulin variable domain sequence; the protein ligand binds to Tie1 ectodomain, a receptor tyrosine kinase protein that includes a transmembrane domain; use in modulating angiogenesis |
| 03/25/2008 | CA2115579C Ryegrass pollen allergen |
| 03/20/2008 | WO2008033159A1 Influenza antibodies, compositions, and related methods |
| 03/20/2008 | WO2008033106A1 Binding domain of plasmodium reticulocyte binding proteins |
| 03/20/2008 | WO2008033105A1 Hemagglutinin antibody and uses thereof |
| 03/20/2008 | WO2008033044A1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy |
| 03/20/2008 | WO2008032833A1 Antibody having enhanced adcc activity and method for production thereof |
| 03/20/2008 | WO2008032760A1 Detection marker for cervical cancer, and detection kit and cervical cancer determination method using the marker |
| 03/20/2008 | WO2008032748A1 Transgenic silkworm capable of producing functional antibody molecule |
| 03/20/2008 | WO2008032712A1 Monoclonal antibody and use thereof |
| 03/20/2008 | WO2008031842A1 Inhibitors of gpr87 for cancer therapy |
| 03/20/2008 | WO2008031626A1 Treatment of multiple sclerosis (ms) with campath-1h |
| 03/20/2008 | WO2008031577A1 Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| 03/20/2008 | WO2008031531A1 Tumor therapy with a combination of anti-her2 antibodies |
| 03/20/2008 | WO2008002572A3 Method for measuring mature brain derived neurotrophic factor |
| 03/20/2008 | WO2007148065A3 Antibody for anthrax |